Neurology 1512 - Neurology Alert - Dec 01, 2011

Target Audience:

This activity is intended for the neurologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
John J. Caronna, MD
Professor of Clinical Neurology;
Specialty area, Stroke and General Neurology

Susan A. Gauthier, DO, MPH
Assistant Professor of Neurology;
Specialty area, Multiple Sclerosis

Michael Rubin, MD, FRCP(C)

Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders

Dara G. Jamieson, MD
Associate Professor of Clinical Neurology;
Specialty area, Headache


William Cobb, MD,
Graduate Staff
New York Presbyterian Hospital/Weill Cornell Medical Center

Theodore H. Schwartz, MD, PhD
Professor of Neurosurgery, Otolaryngology, Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital


  • When Is it Best to Evaluate the Results of a CSF Tap Test?
  • Teriflunomide: A New Oral Agent for the Treatment of Multiple Sclerosis
  • Rituximab May Be Effective for Refractory Myasthenia Gravis
  • Surgical Treatment of Brain Metastases
  • Women with Migraine: Options for Decreasing Disability
  • Stroke Alert: A Review of Current Clinical Stroke Literature


  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Assistant editors John J. Caronna, MD, Susan A. Gauthier, DO, MPH, Michael Rubin, MD, FRCP(C), Dara G. Jamieson, MD, authors William Cobb, MD, and Theodore H. Schwartz, MD, PhD, and peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Copyright 2011 AHC Media LLC. All rights reserved.